An analysis, not an investment advice. Trade SAFE, trade PATIENTLY & say NO to GREED.
ノート
ACB filed for 750 million shares to be added. Very unexpected and questionable by the company. We may see a further pullback.
ノート
Up we go! ACB has been selected by the German Bundesinstitut für Arzneimittel und Medizinprodukte BfArM as one of three winners in the public tender to cultivate and distribute medical cannabis in Germany.